R21/Matrix-M: WHO Paves Way for Oxford-Serum Malaria Vaccine’s Global Use
Pune: The R21/Matrix-M malaria vaccine developed by the University of Oxford and the Serum Institute of India, leveraging Novavax’s adjuvant technology, ...
Pune: The R21/Matrix-M malaria vaccine developed by the University of Oxford and the Serum Institute of India, leveraging Novavax’s adjuvant technology, ...
Pune: The government has approved the export of BCG vaccine manufactured by the Serum Institute of India to Canada for ...
New Delhi: Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday said it has restarted manufacturing of COVID-19 vaccine ...
New Delhi: Amid rising coronavirus cases, the Serum Institute of India has written a letter to the Union health ministry ...
Pune: The Serum Institute of India (SII) has sought the drug regulator's approval for market authorisation of its COVID-19 vaccine ...
The Drugs Controller General of India (DCGI) has approved export of the country’s first indigenously developed vaccine against malaria to ...
Singapore: Multilateral organisations like the UN and the WTO should take it upon themselves to harmonise the certification of vaccines ...
Mumbai: The Serum Institute of India (SII), Pune has become the latest target of cyber fraudsters who reportedly duped the ...
New Delhi: India’s first indigenously developed Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer is all set to launch on ...
Hyderabad: The Serum Institute of India (SII) on Friday said that the price of a booster dose of Covishield will ...
© 2024 pragativadi.com